TTrialPathMatch Me to Trials
← Back to trials
RecruitingcGVHD

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Eligible age

18+ yrs

Accepts

All genders

Locations

24 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

Sponsor: Incyte Corporation

You may qualify if…

  • Age ≥ 18 years inclusive at the time of signing the ICF
  • Allogeneic SCT 90 to 180 days prior to enrollment
  • Able to comprehend and willing to provide informed consent
  • Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel

You may not qualify if…

  • There are no exclusion criteria for this study

Where it's recruiting

Alabama

Birmingham

Arizona

Phoenix

California

Duarte · Los Angeles

Colorado

Aurora

Florida

Jacksonville · Orlando

Georgia

Atlanta · Augusta

Illinois

Chicago · Maywood

Kansas

Fairway

Louisiana

New Orleans

Maryland

Baltimore

Michigan

Grand Rapids

Source: ClinicalTrials.gov · NCT05919511 · last updated 2026-08-25

Observational Study for Patients at Risk for Chronic Graft-Versus-Host · TrialPath